Kazia Therapeutics Limited KZIA

Full chart Compare
Set alert

Price alert · KZIA

All alert types
7.65 USD -0.43 (-5.32%)

Nov 5, 2026, 9:54 AM EST

7.65 Day range 7.99
4.86 52-week range 17.40
YTD
+11.03%
1 year
-0.39%

Revenue & Expenses

Other Operating Income → Expenses: $1.79MIncome Tax Benefit → Expenses: $1.75MExpenses → Selling, General & Admin: $8.72MExpenses → Research & Development: $7.33MExpenses → Other Expenses: $8.23MGross Profit → Expenses: $42.00KRevenue → Gross Profit: $42.00KNet Loss → Expenses: $20.70MOther Operating Income$1.79MIncome Tax Benefit$1.75MGross Profit$42.00KNet Loss$20.70MExpenses$24.28MSelling, General & Admin$8.72MResearch & Development$7.33MOther Expenses$8.23MRevenue$42.00K

Latest period ending Jun 30, 2025 · select a line to chart its full history

KZIA annual income statement
Fiscal yearFY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022FY 2021 Jun 30, 2021
1.83M2.48M1.00K25.00K15.23M
1.83M2.48M1.00K25.00K15.23M
-27.60M-28.46M-24.15M-25.26M-6.33M
-20.70M-26.78M-20.46M-25.01M-8.42M
-3.78-10.16-11.23-94.00-35.80
KZIA annual balance sheet
Fiscal yearFY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022FY 2021 Jun 30, 2021
4.34M1.66M5.24M7.36M27.59M
6.06M21.59M28.08M35.89M57.09M
14.36M31.60M16.03M17.61M19.24M
3.55M7.11M1.80M1.84M0
-8.30M-10.02M12.05M18.27M37.85M
KZIA annual cash flow
Fiscal yearFY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022FY 2021 Jun 30, 2021
-13.28M-9.58M-15.16M-22.76M-9.11M
15.98M5.99M12.97M3.73M28.11M
2.70M-3.60M-2.18M-21.40M19.00M